ArticleAJPM focus2026
Decreasing Prevalence of Chronic Kidney Disease Among U.S. Adults With Diabetes, 1999-2018.
Article in AJPM focus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Introduction: The prevalence of chronic kidney disease among persons with diabetes in the U.S. appears to be decreasing. Understanding the reasons for this decrease is an important health policy issue. Methods: Data on 7,320 adults with diabetes from National Health and Nutrition Examination Survey (1999-2018) were examined to estimate the prevalence of chronic kidney disease in 4-year cohorts. Chronic kidney disease was defined by an estimated glomerular filtration rate <60 ml/min/1.73m Results: The prevalence of chronic kidney disease among individuals with diabetes decreased from 40.5% to 35.4% over 20 years ( Conclusions: The prevalence of chronic kidney disease among participants with diabetes has decreased steadily in the U.S. over the past 20 years, mostly from reductions in the prevalence of albuminuria. Improvements in medical management may explain part of the decrease. Individuals adopting healthy lifestyle behaviors may further explain the decrease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.